Zimmer Biomet Holdings to Present at Raymond James & Associates' 41st Annual Institutional Investors Conference

Loading...
Loading...

WARSAW, Ind., Feb. 28, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in Raymond James & Associates' 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando.  Suky Upadhyay, Executive Vice President and Chief Financial Officer and Keri Mattox, Senior Vice President, Investor Relations and Chief Communications Officer, will present for the Company on Monday, March 2, 2020, at 9:50 a.m. Eastern Time.

ZIMMER BIOMET INC. LOGO (PRNewsFoto/Zimmer Holdings, Inc.)

A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

ZBH-Con

SOURCE Zimmer Biomet Holdings, Inc.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releasestrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...